A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Diazoxide Choline in Non-Diabetic Hypertriglyceridemic Subjects.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Diazoxide Choline in Non-Diabetic Hypertriglyceridemic Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2015

At a glance

  • Drugs Diazoxide (Primary)
  • Indications Hyperlipoproteinaemia type V; Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2009 Primary endpoint 'Triglyceride levels' has been met, according to an Essentialis Therapeutics media release.
    • 15 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Nov 2008 Enrollment in this trial has been completed, according to an Essentialis media release. 92 patients have been enrolled.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top